Donald Mainland: anatomist, educator, thinker, medical statistician, trialist, rheumatologist.
作者信息
Altman Doug
机构信息
Centre for Statistics in Medicine, University of Oxford, Botnar Research Centre, Oxford OX3 7LD, UK.
出版信息
J R Soc Med. 2020 Jan;113(1):28-38. doi: 10.1177/0141076819896274.
Abstract
摘要
相似文献
1
Donald Mainland: anatomist, educator, thinker, medical statistician, trialist, rheumatologist.唐纳德·梅因兰：解剖学家、教育家、思想家、医学统计学家、试验专家、风湿病学家。
J R Soc Med. 2020 Jan;113(1):28-38. doi: 10.1177/0141076819896274.
2
Sir Austin Bradford Hill: an appreciation.
Control Clin Trials. 1992 Apr;13(2):100-5. doi: 10.1016/0197-2456(92)90016-s.
3
Major Greenwood and clinical trials.梅杰·格林伍德与临床试验。
J R Soc Med. 2017 Nov;110(11):452-457. doi: 10.1177/0141076817736028.
4
Oscar B. Crofford: Clinician, scientist, educator, advocate for people with diabetes, and godfather of diabetes control and complications trial.奥斯卡·B·克罗福德：临床医生、科学家、教育家、糖尿病患者权益倡导者，以及糖尿病控制与并发症试验的教父。
Diabetes Care. 2014 Dec;37(12):3139-42. doi: 10.2337/dc14-1601.
5
Reflections on statistics at the London School of Hygiene and Tropical Medicine 30 years ago.30年前对伦敦卫生与热带医学院统计学的思考。
Stat Med. 2000 Dec 15;19(23):3165-70. doi: 10.1002/1097-0258(20001215)19:23<3165::aid-sim618>3.0.co;2-l.
6
[Index of German-language dissertations in the history of medicine and the life sciences (2004-2011)].
Medizinhist J. 2011;46(3-4):283-332.
7
The two-period cross-over clinical trial. 1979.两阶段交叉临床试验。1979年。
Br J Clin Pharmacol. 2004 Dec;58(7):S703-16; discussion S717-9. doi: 10.1111/j.1365-2125.2004.02275.x.
8
The medical sciences in twentieth-century Ireland.
Ir J Med Sci. 2000 Jul-Sep;169(3):221-5. doi: 10.1007/BF03167702.
9
Theory and practice in medical statistics.
Stat Med. 2001;20(17-18):2537-48. doi: 10.1002/sim.727.
10
Men, medicine and machines.
Ir J Med Sci. 1997 Jul-Sep;166(3):152-6. doi: 10.1007/BF02943595.
引用本文的文献
1
Sponsorship bias in clinical trials: growing menace or dawning realisation?临床试验中的赞助偏差：日益严重的威胁还是初现的认识？
J R Soc Med. 2020 Apr;113(4):148-157. doi: 10.1177/0141076820914242.
2
Life, liberty and an independent NHS.生命、自由和独立的国民医疗服务体系。
J R Soc Med. 2020 Jan;113(1):3. doi: 10.1177/0141076819898398.
本文引用的文献
1
PROBLEMS OF CHANCE IN CLINICAL WORK.临床工作中的机遇问题
Br Med J. 1936 Aug 1;2(3943):221-4. doi: 10.1136/bmj.2.3943.221.
2
CHANCE AND THE BLOOD COUNT.机遇与血细胞计数
Can Med Assoc J. 1934 Jun;30(6):656-8.
3
Are reporting standards of diagnostic test evaluation unrealistic?诊断试验评价的报告标准是否不切实际？
J Rheumatol. 2010 Feb;37(2):220-2. doi: 10.3899/jrheum.091254.
4
Statistical methods in medical research; qualitative statistics, enumeration data.
Can J Res. 1948 Feb;26(Sect E 1):1-166. doi: 10.1139/cjr48e-001.
5
The Biomarker-Surrogacy Evaluation Schema: a review of the biomarker-surrogate literature and a proposal for a criterion-based, quantitative, multidimensional hierarchical levels of evidence schema for evaluating the status of biomarkers as surrogate endpoints.生物标志物替代评估方案：对生物标志物替代相关文献的综述以及关于用于评估生物标志物作为替代终点状态的基于标准、定量、多维度层次证据方案的提议。
Stat Methods Med Res. 2008 Jun;17(3):303-40. doi: 10.1177/0962280207082719. Epub 2007 Oct 9.
6
Experiences in the development of multiclinic trials.
J New Drugs. 1961 Sep-Oct;1:197-205. doi: 10.1177/009127006100100502.
7
The use and misuse of statistics in medical publications.
Clin Pharmacol Ther. 1960 Jul-Aug;1:411-22.
8
The clinical trial--some difficulties and suggestions.
J Chronic Dis. 1960 May;11:484-96. doi: 10.1016/0021-9681(60)90013-8.
9
THE SIGNIFICANCE OF "NONSIGNIFICANCE".
Clin Pharmacol Ther. 1963 Sep-Oct;4:580-6. doi: 10.1002/cpt196345580.
10
Notes on the planning and evaluation of research, with examples from cardiovascular investigations. III.
Am Heart J. 1958 Jun;55(6):838-50. doi: 10.1016/0002-8703(58)90100-5.
Zotero 插件